These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 15270200)

  • 1. Metal and inflammatory targets for Alzheimer's disease.
    Rogers JT; Lahiri DK
    Curr Drug Targets; 2004 Aug; 5(6):535-51. PubMed ID: 15270200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Redox-active metals, oxidative stress, and Alzheimer's disease pathology.
    Huang X; Moir RD; Tanzi RE; Bush AI; Rogers JT
    Ann N Y Acad Sci; 2004 Mar; 1012():153-63. PubMed ID: 15105262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the Iron-Response Elements of the mRNAs for the Alzheimer's Amyloid Precursor Protein and Ferritin to Treat Acute Lead and Manganese Neurotoxicity.
    Rogers JT; Xia N; Wong A; Bakshi R; Cahill CM
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30823541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physiological and pathological aspects of Abeta in iron homeostasis via 5'UTR in the APP mRNA and the therapeutic use of iron-chelators.
    Avramovich-Tirosh Y; Amit T; Bar-Am O; Weinreb O; Youdim MB
    BMC Neurosci; 2008 Dec; 9 Suppl 2(Suppl 2):S2. PubMed ID: 19090990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A high-throughput drug screen targeted to the 5'untranslated region of Alzheimer amyloid precursor protein mRNA.
    Bandyopadhyay S; Ni J; Ruggiero A; Walshe K; Rogers MS; Chattopadhyay N; Glicksman MA; Rogers JT
    J Biomol Screen; 2006 Aug; 11(5):469-80. PubMed ID: 16928984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel 5' untranslated region directed blockers of iron-regulatory protein-1 dependent amyloid precursor protein translation: implications for down syndrome and Alzheimer's disease.
    Bandyopadhyay S; Cahill C; Balleidier A; Huang C; Lahiri DK; Huang X; Rogers JT
    PLoS One; 2013; 8(7):e65978. PubMed ID: 23935819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's disease therapeutics targeted to the control of amyloid precursor protein translation: maintenance of brain iron homeostasis.
    Bandyopadhyay S; Rogers JT
    Biochem Pharmacol; 2014 Apr; 88(4):486-94. PubMed ID: 24513321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The integrated role of desferrioxamine and phenserine targeted to an iron-responsive element in the APP-mRNA 5'-untranslated region.
    Venti A; Giordano T; Eder P; Bush AI; Lahiri DK; Greig NH; Rogers JT
    Ann N Y Acad Sci; 2004 Dec; 1035():34-48. PubMed ID: 15681799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid precursor protein and alpha synuclein translation, implications for iron and inflammation in neurodegenerative diseases.
    Cahill CM; Lahiri DK; Huang X; Rogers JT
    Biochim Biophys Acta; 2009 Jul; 1790(7):615-28. PubMed ID: 19166904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FDA-preapproved drugs targeted to the translational regulation and processing of the amyloid precursor protein.
    Morse LJ; Payton SM; Cuny GD; Rogers JT
    J Mol Neurosci; 2004; 24(1):129-36. PubMed ID: 15314261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer's disease drug discovery targeted to the APP mRNA 5'untranslated region.
    Rogers JT; Randall JD; Eder PS; Huang X; Bush AI; Tanzi RE; Venti A; Payton SM; Giordano T; Nagano S; Cahill CM; Moir R; Lahiri DK; Greig N; Sarang SS; Gullans SR
    J Mol Neurosci; 2002; 19(1-2):77-82. PubMed ID: 12212798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metal Ions in Alzheimer's Disease: A Key Role or Not?
    Liu Y; Nguyen M; Robert A; Meunier B
    Acc Chem Res; 2019 Jul; 52(7):2026-2035. PubMed ID: 31274278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA therapeutics directed to the non coding regions of APP mRNA, in vivo anti-amyloid efficacy of paroxetine, erythromycin, and N-acetyl cysteine.
    Tucker S; Ahl M; Cho HH; Bandyopadhyay S; Cuny GD; Bush AI; Goldstein LE; Westaway D; Huang X; Rogers JT
    Curr Alzheimer Res; 2006 Jul; 3(3):221-7. PubMed ID: 16842099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron and the translation of the amyloid precursor protein (APP) and ferritin mRNAs: riboregulation against neural oxidative damage in Alzheimer's disease.
    Rogers JT; Bush AI; Cho HH; Smith DH; Thomson AM; Friedlich AL; Lahiri DK; Leedman PJ; Huang X; Cahill CM
    Biochem Soc Trans; 2008 Dec; 36(Pt 6):1282-7. PubMed ID: 19021541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel drug targets based on metallobiology of Alzheimer's disease.
    Bandyopadhyay S; Huang X; Lahiri DK; Rogers JT
    Expert Opin Ther Targets; 2010 Nov; 14(11):1177-97. PubMed ID: 20942746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory Activities of Dopamine and Its Derivatives toward Metal-Free and Metal-Induced Amyloid-β Aggregation, Oxidative Stress, and Inflammation in Alzheimer's Disease.
    Nam E; Derrick JS; Lee S; Kang J; Han J; Lee SJC; Chung SW; Lim MH
    ACS Chem Neurosci; 2018 Nov; 9(11):2655-2666. PubMed ID: 29782798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presence of a "CAGA box" in the APP gene unique to amyloid plaque-forming species and absent in all APLP-1/2 genes: implications in Alzheimer's disease.
    Maloney B; Ge YW; Greig N; Lahiri DK
    FASEB J; 2004 Aug; 18(11):1288-90. PubMed ID: 15208260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The novel multitarget iron chelating and propargylamine drug M30 affects APP regulation and processing activities in Alzheimer's disease models.
    Amit T; Bar-Am O; Mechlovich D; Kupershmidt L; Youdim MBH; Weinreb O
    Neuropharmacology; 2017 Sep; 123():359-367. PubMed ID: 28571715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Divalent metal transporter 1 is involved in amyloid precursor protein processing and Abeta generation.
    Zheng W; Xin N; Chi ZH; Zhao BL; Zhang J; Li JY; Wang ZY
    FASEB J; 2009 Dec; 23(12):4207-17. PubMed ID: 19679638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simvastatin ameliorate memory deficits and inflammation in clinical and mouse model of Alzheimer's disease via modulating the expression of miR-106b.
    Huang W; Li Z; Zhao L; Zhao W
    Biomed Pharmacother; 2017 Aug; 92():46-57. PubMed ID: 28528185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.